CVI Investments, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for Decoy Therapeutics Inc. (f/k/a Salarius Pharmaceuticals, Inc.) Common Stock, $0.0001 par value per share (DCOY)

Filing Manager
CVI Investments, Inc.
Reporting Manager
CVI Investments, Inc.
Security
Decoy Therapeutics Inc. (f/k/a Salarius Pharmaceuticals, Inc.) Common Stock, $0.0001 par value per share
Symbol
DCOY
Shares outstanding
7,157,222 shares
Disclosed Ownership
708,565 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 14:47:30 UTC
Date of event
31 Dec 2025
Previous filing
18 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CVI Investments, Inc. 9.9% 708,565 0 708,565 /s/ Sarah Travis Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc. 9.9% 708,565 0 708,565 /s/ Sarah Travis Sarah Travis, Assistant General Counsel and Assistant Secretary